Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03943875
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:09.500924+00:00
Published At
2026-02-17T00:00:00+00:00
Record Updated At
2026-04-16
Results Posted At
2026-02-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Immunization", "Efficacy", "Human Papilloma Virus"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-16"
protocolSection.identificationModule.nctId
"NCT03943875"
protocolSection.identificationModule.officialTitle
"GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-02-17"

Study condition terms

  • Immunization (protocolSection.conditionsModule.conditions)
  • Efficacy (protocolSection.conditionsModule.conditions)
  • Human Papilloma Virus (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.